Kaleido Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb '26 Feb 12, 2026	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	0	102	327	151	-	-
Market Cap Growth	0%	-68.91%	117.13%	-	-	-
Enterprise Value	-	68	294	84	-	-
Last Close Price	0.00	2.39	9.10	5.02	-	-
PS Ratio	0.00	92.21	335.83	-	-	-
PB Ratio	0.00	9.60	15.98	3.09	-	-
P/TBV Ratio	0.00	9.60	15.98	3.09	-	-
EV/Sales Ratio	-	61.29	301.27	-	-	-
Debt / Equity Ratio	2.05	2.05	1.02	0.42	0.26	1.69
Net Debt / Equity Ratio	-1.58	-1.58	-1.23	-1.04	-1.07	-1.54
Net Debt / EBITDA Ratio	0.20	0.20	0.33	0.60	1.02	0.51
Net Debt / FCF Ratio	0.22	0.22	0.39	0.64	1.24	0.57
Asset Turnover	0.02	0.02	0.01	-	-	-
Quick Ratio	1.33	1.33	2.78	6.87	6.73	7.40
Current Ratio	1.43	1.43	2.93	7.06	6.75	7.41
Return on Equity (ROE)	-580.57%	-580.57%	-235.29%	-163.10%	-187.68%	-729.65%
Return on Assets (ROA)	-99.93%	-99.93%	-69.77%	-64.62%	-65.35%	-94.55%
Return on Capital Employed (ROCE)	-427.90%	-427.90%	-185.20%	-120.50%	-82.00%	-100.50%
Earnings Yield	-2118442.05%	-88.69%	-24.93%	-57.25%	-	-
FCF Yield	-1835358.99%	-76.84%	-20.02%	-52.64%	-	-
Buyback Yield / Dilution	-25.14%	-25.14%	-30.14%	-403.18%	-14.29%	-19.13%

Updated Apr 1, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.